Elon Musk Quotes

With Halcyon's technology, the pool of genetic information will grow by orders of magnitude in the course of months, offering the first real chance at cures for cancer and other previously intractable diseases.

Even if we never cure a single disease, the Human Genome Project and other ventures will have been worth it.

Scientists have established huge numbers of links between particular diseases and snippets of DNA, but in the great majority of cases, this has not yet been translated into treatments that can help cure patients. These treatments will come - tomorrow, or the day after.

My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson's diseases, diabetes or blood diseases.

I think there are people who's lives have been saved because of the study of the genome.

I'm hoping that these next 20 years will show what we did 20 years ago in sequencing the first human genome, was the beginning of the health revolution that will have more positive impact in people's lives than any other health event in history.

And of course, identifying all human genes and proteins will have great medical significance.

Now, as the world's scientists focus with increasing intensity on transforming the genetic codes of every living creature into information that can be used to treat and ultimately prevent disease, Shenzhen is home to a different kind of factory: B.G.I., formerly called Beijing Genomics Institute, the world's largest genetic-research center.

What does gene A do? What does gene B do? What does it do in different contexts? What's its importance? We know the answer to that for a very small number of genes, the ones that made themselves evident many years ago.

The Human Genome Project has given us a genetic parts list.

Funding that is focused on the ability to diagnose diseases precisely will just have inestimable value because that's the gate through which precision medicine has to go. Unless you can diagnose the disease precisely, care has to remain in the hands of expensive institutions and expensive caregivers.

We know specific genes are turned on in specific cells, but we don't know to what extent this happens.

If genetic research doesn't seemed to have lived up to its therapeutic promise, it's because sequencing is just too slow and expensive.

The identification of the genes which determine biological phenomena and the study of the control they exert on these phenomena has proven to be the most successful approach to a detailed understanding of the mechanism of biological processes.

An important finding is that by determining the genome sequences of an entire family, one can identify many DNA sequencing errors and thus greatly increase the accuracy of the data. This will ultimately help us understand the role of genetic variations in the diagnosis, treatment, and prevention of disease.

Our understanding of how DNA informs our health and development is advancing at an incredible pace.

The inability to trace DNA to actual diseases has serious consequences. As does the opposite problem - not being able to trace diseases back to DNA.

Applying smarter IT to genomic data may offer the potential to cure many types of cancer and other diseases.

Genomics is a new idea. Like the PC, it's not obvious at first that anyone would want one. It's like, 'Hey, we've already got one genome, why do we need more?'

We can change the expression of more than 70 percent of the genes that have a direct bearing on our health and longevity.

Although not yet routine, many cancer centers have the technology to sequence some or all of a patient's cancer genome. This can provide massive amounts of valuable information about your cancer, including whether you have genetic mutations and other abnormalities for which new drugs are available.

A person's health isn't generally a reflection of genes, but how their environment is influencing them. Genes are the direct cause of less than 1pc of diseases: 99pc is how we respond to the world.

Making personalized medicine a reality will require a strong partnership between 23andMe and the physician and medical communities.

Our approach to medicine is very 19th-century. We are still in the dark ages. We really need to get to the molecular level so that we are no longer groping about in the dark.

My own area of expertise is the genetics of human disease. I was fortunate to be part of the team that found the genes for cystic fibrosis, and Huntington's disease and neurofibromatosis.